The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Expansion In Market Value Is Forecasted For The COVID-19 Current Therapy Market Between 2026 And 2030?
The covid-19 current therapy market size has seen a sharp reduction in recent years. It is anticipated to fall from $2.35 billion in 2025 to $1.57 billion in 2026, at a compound annual growth rate (CAGR) of -33.2%. The historical decrease can be linked to the sudden emergence of covid-19, elevated hospitalization rates, restricted initial therapeutic choices, diminishing government and healthcare initiatives, and fewer emergency drug approvals.
The covid-19 current therapy market size anticipates a significant reduction over the upcoming years. By 2030, this market is projected to reach $0.31 billion, experiencing a compound annual growth rate (CAGR) of -33.2%. This projected decrease stems from factors such as reduced telemedicine adoption for covid-19 management and limited growth in home care services. Key developments expected during this period involve a surge in the use of antiviral and monoclonal antibody therapies, greater application of corticosteroids for severe covid-19 cases, an increase in home care and remote patient monitoring for covid-19, broader availability of supplement and immune support therapies, and the incorporation of combination and experimental therapies into treatment plans.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3247&type=smp
Which Key Drivers Are Affecting The COVID-19 Current Therapy Market Development?
The growing healthcare infrastructure is anticipated to boost the COVID-19 current therapy market’s expansion in the future. The healthcare industry involves combining and incorporating various economic sectors that deliver products and services for treating, preventing, rehabilitating, and offering palliative care to patients. A strong healthcare infrastructure is essential for the successful deployment of COVID-19 therapies, guaranteeing prompt patient care, assisting research and clinical trials, and supplying necessary resources for the best possible treatment delivery. For example, data from May 2023, released by the American Health Care Association, a US-based nonprofit entity, showed that the number of hospitals in the US rose to 6,129 from 6,093 in 2022. Additionally, in May 2023, a report from the Office for National Statistics, a UK-based government body, indicated a substantial increase in healthcare spending in the UK, reaching 9.4% in nominal terms and 9.7% in real terms. Thus, the growth of the healthcare sector is propelling the expansion of the COVID-19 current therapy market.
How Is Segmentation Applied In The COVID-19 Current Therapy Market Segment Analysis?
The covid-19 current therapy market covered in this report is segmented –
1) By Drug Type: Antiviral, Monoclonal Antibodies, Corticosteroid, Supplements, Antimalarial, Interferons And Interleukin Inhibitors, Other Anti-Infective Drugs
2) By Route Of Administration: Oral, Intravenous
3) By End-User: Hospitals, Clinics, Home Care, Others
Subsegments:
1) By Antiviral: Remdesivir, Oseltamivir, Favipiravir, Nirmatrelvir Or ritonavir (Paxlovid)
2) By Monoclonal Antibodies: Bamlanivimab, Casirivimab Or Imdevimab (REGEN-COV), Sotrovimab, Etesevimab
3) By Corticosteroid: Dexamethasone, Hydrocortisone, Prednisone
4) By Supplements: Vitamin D, Vitamin C, Zinc, Quercetin
5) By Antimalarial: Hydroxychloroquine, Chloroquine
6) By Interferons and Interleukin Inhibitors: Interferon beta-1a, Interleukin-6 inhibitors
7) By Other Anti-Infective Drugs: Antibiotics, Antifungal Agents
Which Trends Are Contributing To Changes In The COVID-19 Current Therapy Market?
Major companies operating in the COVID-19 current therapy market are increasingly focusing on introducing innovative products, such as COVID-19 oral antiviral treatment, to gain a competitive edge. Antiviral treatment refers to the use of medications designed to inhibit the replication and spread of viruses within the body. For instance, in April 2024, Invivyd, a US-based company focused on developing antibody-based therapies to address serious viral infectious diseases, provided an update on the launch of PEMGARDA™. This followed its emergency use authorization (EUA) from The U.S. Food and Drug Administration (FDA). PEMGARDA quickly became available for commercial use. This treatment is aimed at preventing COVID-19 in individuals with moderate-to-severe immune compromise.
Who Are The Companies Participating In The COVID-19 Current Therapy Market Environment?
Major companies operating in the covid-19 current therapy market are Gilead Sciences Inc., Ipca Laboratories Limited, Zydus Cadila, Regeneron Pharmaceuticals Inc., Sun Pharmaceutical Industries Limited, AbbVie, Glenmark Pharmaceuticals Limited, Eli Lilly and Company, Wallace Pharmaceuticals Inc., Canary Health Technologies, Thermo Fisher Scientific
Get The Full COVID-19 Current Therapy Market Report:
https://www.thebusinessresearchcompany.com/report/coronavirus-current-therapy-global-market-report
Which Region Holds The Highest Market Share In The COVID-19 Current Therapy Market?
North America is the largest region in the COVID-19 current therapy market in 2025. Middle East is expected to be the fastest-growing region in the global COVID-19 current therapy market share during the forecast period. The regions covered in the covid-19 current therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized COVID-19 Current Therapy Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/report/coronavirus-current-therapy-global-market-report
Browse Through More Reports Similar to the Global COVID-19 Current Therapy Market 2026, By The Business Research Company
Hydroxychloroquines Market Report 2026
https://www.thebusinessresearchcompany.com/report/hydroxychloroquines-global-market-report
Covid 19 Detection Test Kits And Consumables Market Report 2026
Covid 19 Rapid Test Kits Market 2026
https://www.thebusinessresearchcompany.com/report/covid-19-rapid-test-kits-market
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model